| Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis. | Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
Guo C, Zhang M, Jin X, Zhu C, Qian J, Tao M. | 05/9/2024 |
| IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay. | IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay.
Liu X, Wu P, Su R, Xue Y, Yang C, Wang D, Ruan X, Zheng J, Yang Y, Li Z, Liu Y., Free PMC Article | 09/18/2021 |
| Analysis of associations of FBXL19-AS1 with occurrence, development and prognosis of acute pancreatitis. | Analysis of associations of FBXL19-AS1 with occurrence, development and prognosis of acute pancreatitis.
Ma Q, Gan GF, Niu Y, Tong SJ. | 07/3/2021 |
| Long noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by sponging miR-203a-3p in lung adenocarcinoma. | Long noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by sponging miR-203a-3p in lung adenocarcinoma.
Wang L, Zhang X, Liu Y, Xu S. | 02/6/2021 |
| LncRNA FBXL19-AS1 promotes the development of gastric cancer by regulating miR-876-5p/ HMGB3 axis. | LncRNA FBXL19-AS1 promotes the development of gastric cancer by regulating miR-876-5p/ HMGB3 axis.
Ji RX, Ren F, Liu XQ, Yuan X. | 02/2/2021 |
| Long non-coding RNA FBXL19-AS1 serves as a competing endogenous RNA to regulate ZEB1 expression by sponging miR-431 in gastric cancer. | Long non-coding RNA FBXL19-AS1 serves as a competing endogenous RNA to regulate ZEB1 expression by sponging miR-431 in gastric cancer.
Wang XL, Wang JL, Ma W, Jiang Y, Wan JH, Jiang SJ, He ZK, Wang XJ, An ZY, Liu XX, Cui RJ. | 01/23/2021 |
| LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer. | LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ, Li YH, Zhong M. | 10/3/2020 |
| This study revealed the regulatory mechanism of FBXL19-AS1 in breast cancer and suggested a comprehensive and feasible FBXL19-AS1-mediated therapeutic approach for treating breast cancer. | FBXL19-AS1 promotes cell proliferation and inhibits cell apoptosis via miR-876-5p/FOXM1 axis in breast cancer.
Dong G, Pan T, Zhou D, Li C, Liu J, Zhang J. | 02/29/2020 |
| FBXL19-AS1 expression and role in cell migration, invasion, and epithelial-mesenchymal transition in breast cancer.LIN28A-stabilized FBXL19-AS1. | LIN28A-stabilized FBXL19-AS1 promotes breast cancer migration, invasion and EMT by regulating WDR66.
Zhang Y, Xiao X, Zhou W, Hu J, Zhou D. | 12/21/2019 |
| these results indicated that FBXL19-AS1 was involved in progression and angiogenesis in lung cancer by targeting miR-431-5p/RAF1 axis, which provided a new insight into the therapeutic strategies of lung cancer. | FBXL19-AS1 exerts oncogenic function by sponging miR-431-5p to regulate RAF1 expression in lung cancer.
Jiang Q, Cheng L, Ma D, Zhao Y., Free PMC Article | 07/27/2019 |
| results reveal the cancer-promoting effect of FBXL19-AS1, acting as a molecular sponge in negatively modulating miR-203, which might provide a new insight for understanding of colorectal cancer development | Long non-coding RNA FBXL19-AS1 plays oncogenic role in colorectal cancer by sponging miR-203.
Shen B, Yuan Y, Zhang Y, Yu S, Peng W, Huang X, Feng J. | 09/23/2017 |